HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stride, A. Articles by Hattersley, A. T. Search for Related Content PubMed PubMed Citation Articles by Stride, A. Articles by Hattersley, A. T. Social Bookmarking                What's this?

ß-Cell Dysfunction, Insulin Sensitivity, and Glycosuria Precede Diabetes in Hepatocyte Nuclear Factor-1 Mutation Carriers

¹ Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, Devon, U.K
² Regional Endocrine Laboratory, University Hospital Birmingham National Health Service (NHS) Foundation Trust, Birmingham, U.K
³ Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, U.K

Address correspondence and reprint requests to Professor Andrew Hattersley, Peninsula Medical School, the Royal Devon and Exeter NHS Foundation Trust, Barrack Road, Exeter, Devon, U.K. E-mail: a.t.hattersley{at}ex.ac.uk

OBJECTIVE—Patients with diabetes due to hepatocyte nuclear factor (HNF)-1 mutations have ß-cell deficiency, insulin sensitivity, altered proinsulin levels, and a low renal threshold for glucose. It is uncertain how many of these features precede the development of diabetes. The aim of our study was to test for these characteristics in young nondiabetic HNF-1 mutation carriers.

RESEARCH DESIGN AND METHODS—A total of 47 offspring from 19 extended families underwent genetic testing, a standard oral glucose tolerance test, and urine testing.

RESULTS—HNF-1 mutations were found in 20 offspring, 7 with diabetes and 13 without diabetes. The 13 nondiabetic mutation carriers were compared with 27 family control subjects, who were matched for age, sex, and BMI. There was marked ß-cell deficiency with reduced insulinogenic index (53.5 [31.5–90.9] vs. 226.0 [126.0–407.1], SD [range], P < 0.001) and area under the curve for insulin (P < 0.001). Insulin sensitivity was increased in mutation carriers (homeostatic model assessment of insulin sensitivity 144.6 [82.7–252.7] vs. 100 [66.9–149.4], P = 0.025). A total of 38% of mutation carriers had glycosuria at 2 h compared with 0% of control subjects (P = 0.0034). Those with glycosuria had peak glucose values that were higher than the mutations carriers without glycosuria (range 8.1–11.8 vs. 6.2–8.4 mmol/l, P = 0.002). The seven subjects with diabetes all showed glycosuria.

CONCLUSIONS—We conclude that marked ß-cell deficiency, increased insulin sensitivity, and a low renal threshold are present in young nondiabetic HNF-1 mutation carriers. The presence of glycosuria post–glucose load could be used to screen children of mutation carriers as it occurs in all mutation carriers with a peak glucose in the oral glucose tolerance test >8.4 mmol/l.

Abbreviations: AUC, area under the curve • FPG, fasting plasma glucose • HNF, hepatocyte nuclear factor • HOMA, homeostatic model assessment • IGT, impaired glucose tolerance • MODY, maturity-onset diabetes of the young • NGT, normal glucose tolerance • OGTT, oral glucose tolerance test

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Skupien, S. Gorczynska-Kosiorz, T. Klupa, K. Wanic, E. A. Button, J. Sieradzki, and M. T. Malecki Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1{alpha} Maturity-Onset Diabetes of the Young Diabetes Care, August 1, 2008; 31(8): 1496 - 1501. [Abstract] [Full Text] [PDF]

				M. Vaxillaire and P. Froguel Monogenic Diabetes in the Young, Pharmacogenetics and Relevance to Multifactorial Forms of Type 2 Diabetes Endocr. Rev., May 1, 2008; 29(3): 254 - 264. [Abstract] [Full Text] [PDF]

				B. Liljestrom, T. Tuomi, B. Isomaa, L. Sarelin, K. Aktan-Collan, and H. Kaariainen Adolescents at Risk for MODY3 Diabetes Prefer Genetic Testing Before Adulthood Diabetes Care, June 1, 2007; 30(6): 1571 - 1573. [Full Text] [PDF]

				A. T. Hattersley and E. R. Pearson Minireview: Pharmacogenetics and Beyond: The Interaction of Therapeutic Response, {beta}-Cell Physiology, and Genetics in Diabetes Endocrinology, June 1, 2006; 147(6): 2657 - 2663. [Abstract] [Full Text] [PDF]